Press release
Alzheimer's Association Long Island's First Annual East End Walk to End Alzheimer's Engages and Inspires Eastern long Island
SOUTHAMPTON, NY (September 20, 2011) — Alzheimer’s Association Long Island is inviting Eastern Long Island residents to unite in a movement to reclaim the future for millions by participating in the first annual Alzheimer’s Association Long Island’s East End Walk to End Alzheimer’s. Its satellite office at 33 Flying Point Road, Suites 121/122 in Southampton will be the site of the Chapter’s kick-off event on Saturday, October 1 at 7:30 a.m.The Walk will be preceded by a grand opening of the Southampton office. The new office will allow care consultants to schedule family meetings to provide information for families or individuals on the East End of Long Island who are coping with Alzheimer’s disease. Alzheimer’s Association Long Island staff members and invited local elected officials will be joined by Cory Leible, a 70-year-old resident of Southampton who will be walking to raise funds in support of the fight against Alzheimer’s disease for the past seven years.
At 8:00 a.m., Mr. Leible will start his walk from the Southampton office and head toward Gurney’s Inn at 290 Old Montauk Highway. At 3:00 p.m., the walkers will meet up with Mr. Leible at the East Hampton Nature Preserve and join him for the last five kilometers (3.1 miles) of the Walk.
Walk to End Alzheimer’s is more than a walk. It is an experience for the participants in Eastern Long Island who will learn about Alzheimer’s disease and how to get involved with this critical cause, from advocacy opportunities, the latest in Alzheimer’s research and clinical trial enrollment to support programs and services. Each walker will also join in a meaningful ceremony to honor those affected by Alzheimer’s disease.
Alzheimer’s disease is a growing epidemic and is now the nation’s sixth-leading cause of death. As baby boomers age, the number of individuals living with Alzheimer’s disease will rapidly escalate, increasing well beyond today’s estimated 5.4 million Americans living with Alzheimer’s. In addition to the five-kilometer (3.1-mile) walk, participants who raise $100 or more will enjoy a celebratory barbeque at Gurney’s Inn and a special tribute to those who have experienced or are experiencing Alzheimer’s.
“There has never been a greater need for the citizens of the East End of Long Island to join in the fight against Alzheimer’s disease by participating in Walk to End Alzheimer’s,” said Mary Ann Malack-Ragona, an Alzheimer’s Association Long Island Executive Director/Chief Executive Officer. “Funds raised will provide care and support services to the 60,000 residents of Long Island living with Alzheimer’s, while also contributing to advancing critically-needed research.”
For more information, call Mary Ann Malack-Ragona at (631) 820-8068 or visit www.2011eastendwtea.kintera.org/longisland. For more information about Alzheimer’s Association Long Island, visit www.alz.org/longisland.
About the Alzheimer's Association Walk to End Alzheimer’s:
The Alzheimer’s Association Walk to End Alzheimer’s is the nation’s largest event to raise awareness and funds for Alzheimer’s care, support and research. Since 1989, the Alzheimer’s Association mobilized millions of Americans in the Alzheimer’s Association Memory Walk®; now the Alzheimer’s Association is continuing to lead the way with Walk to End Alzheimer’s. Together, we can end Alzheimer’s — the nation’s sixth-leading cause of death.
About the Alzheimer's Association:
The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.
Hank Russell, Public Relations Director
The Public Relations and Marketing Group
156 North Ocean Avenue
Patchogue, NY 11772
(631) 207-1057
hrussell@theprmg.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Association Long Island's First Annual East End Walk to End Alzheimer's Engages and Inspires Eastern long Island here
News-ID: 192677 • Views: …
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…